EN
ES
Shopping Cart
Your Cart is Empty
$0.00
View Cart
Exosome Therapy for Skin & Hair Rejuvenation: Benefits and Results
Exosome Therapy for Skin and Hair: What Research Shows
Exosome therapy is being studied for skin rejuvenation and hair loss, but research findings do not establish that every commercial product delivers the same benefits. The product’s source, contents, delivery method, and regulatory status all matter.
For readers in Miami, one point belongs near the start: the FDA states that there are currently no FDA-approved exosome products. Before considering a treatment, ask what is being offered and what evidence supports that specific use.
What are exosomes?
Exosomes are small extracellular vesicles released by cells. They carry molecules involved in communication between cells. Scientists are investigating how these signals might affect tissue repair and other biological processes.
They are different from stem cells themselves. A biological mechanism observed in a laboratory also does not establish how a finished product will perform on your skin or scalp.
The term “exosome therapy” covers varied preparations. Ask for the product name, manufacturer, source, ingredients, and proposed route rather than relying on the category name.
What does the FDA say?
The FDA consumer alert explains that exosome products intended to treat diseases or conditions generally require FDA approval. Its public safety notification reports serious adverse events involving unapproved products marketed as containing exosomes.
If treatment is proposed as part of a clinical trial, the FDA advises asking about its review and the FDA-issued Investigational New Drug application, or IND. Request the relevant documentation and informed-consent information before participating.
A trial listing or a study conducted overseas does not establish that a product has FDA marketing approval in the United States.
What the skin research shows
Early human studies have assessed wrinkles, hydration, elasticity, pigmentation, and skin texture. Some combine an exosome-containing preparation with another procedure, so the exact study design matters.
One randomized split-face study enrolled 28 people and compared an adipose-derived exosome-containing solution plus microneedling with saline plus microneedling. Over 12 weeks, the solution-treated side showed greater improvement in several skin measurements. The study did not establish the long-term safety or performance of other products or delivery routes.
A clinical evidence review also reports encouraging skin and hair findings, while identifying differences in products and protocols that limit how broadly the results apply. These findings support further research rather than a guaranteed treatment result.
For a discussion of the procedure itself, see Nuceria’s microneedling service in Miami. Adding a separate product requires its own assessment.
What the hair-loss research shows
Hair studies have reported changes in density or thickness, but some test formulations containing multiple ingredients.
A 20-participant pilot trial in men with early male pattern hair loss tested an exosome-containing formulation with two plant extracts. Hair-count changes favored that formulation over placebo at 16 weeks. This small study cannot establish that all exosome products regrow hair or identify the contribution of exosomes separately from the other ingredients.
An accurate diagnosis should come before treatment. The American Academy of Dermatology explains that different types of hair loss require different approaches. For male pattern hair loss, established medication options include topical minoxidil and prescription finasteride; suitability and side effects require discussion with a clinician.
Nuceria’s PRP hair-loss treatment page describes a different approach that can be discussed during assessment. PRP uses a patient’s own blood-derived plasma and should be evaluated on its own evidence.
Topical application, microneedling, and injection
These delivery methods involve different exposures. A study of topical application with microneedling cannot establish the safety of injecting a preparation into the scalp or skin.
Ask how the proposed route compares with the route studied, whether the product is intended for that use, and what regulatory requirements apply. The provider should be able to explain those points for the actual product.
Do not assume that a microneedling device’s regulatory status also covers a serum applied during the procedure.
Results, sessions, and maintenance
There is no established session count or maintenance schedule that applies to all exosome products for skin and hair. Published trials use specific preparations and protocols; their schedules should not become a universal clinic package.
Ask which outcome will be measured, how long follow-up lasts, and what evidence supports the proposed number of visits. Standardized photographs and, for hair concerns, consistent measurements can help make follow-up more useful.
Claims of visible improvement after one visit, permanent follicle reactivation, or guaranteed long-lasting results need product-specific clinical support.
Safety and recovery questions
Risk depends on the preparation, manufacturing controls, route, and any accompanying procedure. Long-term safety remains an important research question. A small study reporting no serious events cannot rule out uncommon complications.
Ask about product testing and handling, possible reactions, aftercare, and the plan for managing complications. Pain, recovery time, and compatibility should not be described in absolute terms.
If you develop a concerning reaction, seek medical care and contact the treating clinician. The FDA encourages reporting adverse events involving these products through MedWatch.
Questions to ask before making a decision
-
What diagnosis explains my skin or hair concern?
-
What is the exact product, source, manufacturer, and ingredient list?
-
What evidence matches this product, treatment area, and delivery route?
-
What is its FDA status, and is the proposed use part of an authorized clinical investigation?
-
What established alternatives should I compare, including choosing no procedure?
-
How will we measure benefit, monitor risks, and decide whether to continue?
-
What does the full cost include, and what happens if the result is disappointing?
Frequently asked questions
Are exosome products FDA approved for hair loss or skin rejuvenation?
The FDA states that there are currently no FDA-approved exosome products. Ask your provider to explain the regulatory status of the exact product and proposed use.
Are exosomes better than PRP?
There is no basis for declaring the entire category superior to PRP. A meaningful comparison requires matched products, indications, delivery methods, and clinical evidence.
Can I use a skin-study result to predict hair regrowth?
Skin and hair outcomes involve different treatment goals and measurements. Evidence for one application cannot reliably predict the other.
How many sessions will I need?
A universal session count has not been established. First confirm the diagnosis, product, regulatory status, and evidence for the proposed plan.
Discuss your skin or hair concerns with Nuceria
Contact Nuceria Health to request an assessment in Miami. Bring your questions about diagnosis, evidence, risks, and alternatives so the provider can explain which options fit your needs.
Request an appointment here: https://mynuceria.com or call Nuceria Health at (305) 398-4370 for an appointment in our Miami office.
Check out what others are saying about our services on Yelp: Wellness Center in Miami, FL.
Related Posts:
Some studies measure NAD-related metabolites in blood, urine, or cells. These measurements can show ...
Explore the benefits, applications, and process of lipofilling, a cosmetic enhancement technique tha...
Discover The Skin Reaper Deep Dive, a premium $3,200 rejuvenation package combining Endolift, Biofil...
Miami’s Luxe October facial deal: Endolift, Biofiller & massage for radiant skin. Save $800 + FREE...